August 2007
Scottish Enterprise Board SE(07)117
Approvals within delegated authority
The following projects were approved within delegated authority during the period 16 August to 13 September. The details are provided below
Operations
High Growth Start Up Unit
The Chief Operating Officer approved funding of £1.8 million for the continuation of the High Growth Start-Up Unit for a further three years until March 2010.
Scottish Co-investment Fund Investments over £250,000
SFX Technologies Ltd
The Investment Team has approved the sum of £250,000 to be invested in SFX Technologies Ltd by way of ordinary shares. SFX Technologies Ltd develops and produces sound delivery technology.
Scottish Venture Fund Investments over £250,000
Haptogen
The Investment Team has approved the sum of £500,000 to be invested in Haptogen by way of a convertible loan with warrant, a cumulative investment of £700,000. Haptogen is involved in the early stage drug discovery – antibody generation.